Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2011-07-13
Original SEC Filing: Click here

---

Webplus: CBPO/20110713/8-K/2_EX-99.1/000.htm SEC Original: exhibit99-1.htm
Company contact FOR RELEASE ON JULY 13, 2011 AT 4:30 p.m. EDT (NY) China Biologic Notified That Guizhou Provincial Government Suspends Implementation of Plan Affecting Plasma Collection Stations TAI’AN, China, July 13, 2011 /PRNewswire-Asia-FirstCall/ – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic,” or the “Company”), a leading plasma-based biopharmaceutical company in China, today announced that the Company has received

---

---

Webplus: CBPO/20110713/8-K/1/000.htm SEC Original: form8k.htm
FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): July 13, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai’an City, Shandong, 271000 People’s Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2011-07-13CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125